Ritanserin

Ritanserin
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2017-05-11 00:00:00
Sponsor The University of Virginia/Benjamin Purow;1215 Lee Street;Charlottesville, Virginia, 22908
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM